ACRS Operating Cash Flow (Statement)
Aclaris Therapeutics Inc · Operating Cash Flow (Statement)
ACRS Operating Cash Flow (Statement)
Latest reported-$62.06Mperiod ending
ACRS TTM Cash from Operations (-$7.64M → -$62.06M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ACRS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -62,059,000 | |
| -52,205,000 | |
| -47,113,000 | |
| -42,920,000 | |
| -9,988,000 | |
| -12,317,000 | |
| -20,075,000 | |
| -17,898,000 | |
| -64,455,000 | |
| -72,787,000 | |
| -78,325,000 | |
| -90,679,000 | |
| -73,939,000 | |
| -72,951,000 | |
| -67,567,000 | |
| -65,527,000 | |
| -68,316,000 | |
| -60,871,000 | |
| -52,134,000 | |
| -43,916,000 | |
| -45,460,000 | |
| -44,060,000 | |
| -38,633,000 | |
| -50,166,000 | |
| -61,375,000 | |
| -71,932,000 | |
| -96,445,000 | |
| -103,303,000 | |
| -109,802,000 | |
| -110,257,000 | |
| -100,811,000 | |
| -91,773,000 | |
| -75,629,000 | |
| -63,876,000 | |
| -54,663,000 | |
| -44,525,000 | |
| -40,716,000 | |
| -40,368,000 | |
| -34,603,000 | |
| -30,668,000 | |
| -31,331,000 | |
| -24,461,000 | |
| -20,369,000 | |
| -18,994,000 | |
| -10,012,000 | |
| -8,794,000 | |
| -7,636,000 |